Imfinzi (Durvalumab)
durvalumab 120 mg/2.4 mL injection, 2.4 mL vial · INJECTION · PBS code 14932X
STREAMLINEDWhat it costs
AU$860.99 PBS-determined price per pack
Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.
- • First listed on the PBS: 2025-08-01.
- • Repeats: 5.
- • PBS program: IN.
Eligibility criteria for subsidised access
The following is the government's own wording from the PBS Schedule, shown unchanged.
Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1
Advanced, metastatic or recurrent endometrial carcinoma
Initial treatment covering the first 6 treatment cycles
Patient must have deficient mismatch repair (dMMR) endometrial cancer, as determined by immunohistochemistry test; AND
The condition must be unsuitable for at least one of the following: (i) curative surgical resection, (ii) curative radiotherapy; AND
The treatment must be initiated in combination with platinum-containing chemotherapy; AND
The condition must be, at treatment initiation with this drug, either: (i) untreated with systemic therapy, (ii) treated with neoadjuvant/adjuvant systemic therapy, but the cancer has recurred or progressed after more than 6 months from the last dose of systemic therapy; AND
Patient must not have received prior treatment with a programmed cell death-1 (PD-1) inhibitor or a programmed cell death ligand-1 (PD-L1) inhibitor for this condition; AND
Patient must have a World Health Organisation (WHO) Eastern Cooperative Oncology Group (ECOG) performance status score no higher than 1 prior to treatment initiation.
Retain all pathology imaging and investigative test results in the patient's medical records.
Sponsor: AstraZeneca Pty Ltd ABN 54 009 682 311
Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.
Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.